Virtus Family Office’s Medifast MED Stock Holding History

Virtus Family Office’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$839K	Hold	79,060	–	–	0.66%	41
2026 Q1	$806K	Hold	79,060	–	–	0.69%	45
2025 Q4	$844K	Hold	79,060	–	–	0.73%	39
2025 Q3	$1.08M	Buy	79,060 +2,314	+3%	+$32.3K	1.01%	35
2025 Q2	$1.08M	Hold	76,746	–	–	1.38%	32
2025 Q1	$1.03M	Hold	76,746	–	–	1.33%	28
2024 Q4	$1.35M	Sell	76,746 -720	-0.9%	-$13.4K	1.7%	27
2024 Q3	$1.48M	Buy	77,466 +2,658	+4%	+$51.2K	1.96%	25
2024 Q2	$1.63M	Buy	74,808 +48,030	+179%	+$1.28M	2.22%	25
2024 Q1	$1.03M	Buy	26,778 +1,520	+6%	+$73.6K	1.64%	24
2023 Q4	$1.7M	Buy	25,258 +6,138	+32%	+$428K	2.84%	20
2023 Q3	$1.46M	Buy	19,120 +4,408	+30%	+$391K	2.65%	20
2023 Q2	$1.38M	Buy	14,712 +4,236	+40%	+$377K	2.56%	17
2023 Q1	$1.1M	Buy	10,476 +55	+0.5%	+$6.09K	2.18%	22
2022 Q4	$1.22M	Buy	10,421 +3,313	+47%	+$386K	2.72%	17
2022 Q3	$770K	Buy	+7,108	New	+$1.02M	1.97%	30

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Virtus Family Office's MED Position: Q2 2026 in Review

Virtus Family Office held its Medifast (MED) position steady in Q2 2026 at 79,060 shares worth $839K. The position accounts for 0.66% of the portfolio, ranked #41.

Virtus Family Office first reported a position in MED in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.7M in Q4 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Virtus Family Office held 79,060 shares of Medifast worth $839K as of Q2 2026.
Virtus Family Office left its Medifast share count unchanged in Q2 2026.
Medifast made up 0.66% of Virtus Family Office's portfolio in Q2 2026, its #41 holding.
Virtus Family Office first reported a position in Medifast in Q3 2022 and has held it in 16 quarters since.
Virtus Family Office's Medifast position peaked at $1.7M in Q4 2023.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Virtus Family Office's 13F filing for Q2 2026, filed 4 Aug 2026.